Summer Safety
Memory Care Simpsonville SC-Summer is here which means more options for time outdoors. Here are some tips to stay safe and healthy this summer as you venture outdoors for some fun in the sun.
FDA Approves Drug to Treat Agitation in Alzheimer’s Dementia
Reading Time: < 1 minute
Agitation seen in dementia is among many of the common causes that lead to caregiver burnout and community/facility placement and can lead to resident quality of life issues. On Thursday, May 11th, the Food and Drug Administration approved, for the first time, a drug to treat agitation symptoms in Alzheimer’s disease. The drug, Rexulti, is an antipsychotic medication whose new approval covers its use as a once-daily treatment to ease emotional symptoms over time. This is the first FDA-approved treatment option for this indication.
Memory Care Simpsonville SC – FDA Approves Drug to Treat Agitation in Alzheimer’s Dementia
Check out these articles from Alzheimer’s News Today, McKnights Long-Term Care News, and the FDA News Release for more information.
